Valmet Partners with Faderco Group for Production Expansion
Valmet Oyj has announced a significant collaboration with Faderco Group, the Algerian tissue manufacturer, to enhance its production capabilities. This partnership marks a pivotal moment in the tissue industry as Faderco invests in a cutting-edge Advantage DCT 200TS tissue line, coupled with an advanced automation package. This state-of-the-art production line will be Faderco's third order from Valmet, positioning the company to double its overall tissue production capacity and redefine quality standards in Northern Africa.
Boosting Tissue Production Capacity
The installation of this new tissue line at Faderco Group's latest mill is anticipated to add a remarkable 65,000 tons to its annual production of high-quality tissue products, catering to both domestic and international markets. This expansion reflects a strategic effort to meet the growing demands in the tissue market and improve supply to export markets across regions such as Southern Europe and Africa.
Innovative Technology for Sustainability
The Advantage DCT 200TS tissue machine is designed with advanced stock preparation and tissue-making solutions that prioritize energy and water efficiency. These solutions will not only reduce operational costs but also ensure consistent quality in output, delivering significant advantages for tissue producers. The CEO of Faderco Group, Amor Habes, emphasized the importance of energy and water efficiency in their region, sharing that previous installations of Valmet's technology have yielded impressive results.
Enhancing Global Reach Through Efficiency
As Faderco Group strives to expand its international presence, the added benefits of lower energy consumption and enhanced paper quality through technologies like the Advantage ViscoNip press are crucial. This collaboration aims to support Faderco's ambition of reliably producing high-quality products that meet the stringent demands of export markets.
Operational Details of the New Tissue Line
The newly designed tissue machine will feature a width of 5.6 meters and an impressive design speed of 2,200 meters per minute, which positions it among the top competitors in the industry. Valmet's delivery will include a comprehensive scope that features not just the Advantage DCT 200TS tissue machine but also two Focus rewinders and an extensive range of auxiliaries.
Automation in Production
To support optimal performance, the delivery will integrate the Valmet DNA Automation System, ensuring streamlined process control and operational efficiency. The approach includes complete mill engineering, start-up supervision, training, and commissioning, which underscores Valmet's commitment to comprehensive support throughout the project.
About Faderco Group and WARAK
Faderco Group, through its subsidiary WARAK, stands as a pioneer in the Algerian hygiene products sector. Founded in 1986, the group has established itself as a leader in North Africa's hygiene market, employing approximately 2,800 individuals and operating multiple production facilities. With a diversified portfolio of 13 brands, the group is well-positioned to cater to both local and international demand, covering various product categories from tissue paper to personal hygiene solutions.
Valmet's partnership with Faderco Group underscores a shared commitment to innovation and sustainability in the tissue industry, paving the way for a more efficient and environmentally responsible future.
Frequently Asked Questions
What is the main agenda behind Valmet's partnership with Faderco Group?
The collaboration aims to double Faderco Group's tissue production capacity through advanced technology, enhancing efficiency and sustainability.
How much additional production does the new tissue line facilitate?
The new line is expected to add an impressive 65,000 tons of tissue paper annually.
What technologies are being implemented in the new tissue line?
The production line will include the Advantage DCT 200TS tissue machine and an automation package ensuring high operational efficiency.
When is the start-up of the new tissue line scheduled?
The start-up is anticipated for the first quarter of 2027.
How does this expansion impact Faderco Group's market presence?
This expansion enables Faderco Group to strengthen its position in both domestic and export markets, enhancing its competitiveness.
